ABL BIOTEC A/S Financials, key figures and credit report
Gross profit - 129.9 kDKK FY 2025 +9.3% vs 2024
EBIT - 129.9 kDKK FY 2025 +52.1% vs 2024
Net debt -27 646.2 kDKK FY 2025 +9.5% vs 2024
Quick ratio 316.8 FY 2025 +224.8 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 130.03 | - 156.46 | - 133.06 | - 143.32 | - 129.95 |
| Employee benefit expenses | - 120.05 | - 120.25 | - 125.98 | - 127.74 | |
| EBIT | - 250.09 | - 276.70 | - 259.03 | - 271.06 | - 129.95 |
| Other financial income | 5 097.39 | 520.33 | 4 940.02 | 5 035.44 | 625.43 |
| Other financial expenses | -49.24 | -3 924.17 | -0.06 | -11.83 | - 631.08 |
| Pre-tax profit | 4 798.06 | -3 680.55 | 4 680.93 | 4 752.54 | - 135.59 |
| Income taxes | -1 066.70 | 805.19 | -1 029.32 | -1 048.12 | 18.87 |
| Net earnings | 3 731.36 | -2 875.36 | 3 651.61 | 3 704.42 | - 116.72 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 5.00 | 237.19 | 3.00 | ||
| Current deferred tax assets | 958.63 | 326.71 | |||
| Short term receivables total | 5.00 | 1 195.81 | 3.00 | 326.71 | |
| Other current investments | 25 419.12 | 24 339.00 | 28 555.28 | 30 357.54 | 27 518.90 |
| Cash and bank deposits | 5 281.13 | 852.03 | 534.59 | 175.77 | 127.27 |
| Cash and cash equivalents | 30 700.25 | 25 191.03 | 29 089.87 | 30 533.30 | 27 646.17 |
| Balance sheet total (assets) | 30 705.25 | 26 386.85 | 29 092.87 | 30 533.30 | 27 972.89 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 |
| Shares repurchased | 600.00 | 1 087.79 | 2 400.00 | 2 200.00 | 1 800.00 |
| Retained earnings | 24 477.06 | 27 120.63 | 21 845.28 | 23 296.89 | 25 201.31 |
| Profit of the financial year | 3 731.36 | -2 875.36 | 3 651.61 | 3 704.42 | - 116.72 |
| Shareholders equity total | 29 808.42 | 26 333.06 | 28 896.89 | 30 201.31 | 27 884.59 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 0.21 | ||||
| Current trade creditors | 28.00 | 28.00 | 23.00 | 30.00 | 30.00 |
| Short-term deferred tax liabilities | 564.24 | 143.91 | 272.92 | ||
| Other non-interest bearing current liabilities | 304.38 | 25.78 | 29.07 | 29.07 | 58.30 |
| Current liabilities total | 896.83 | 53.78 | 195.98 | 331.99 | 88.30 |
| Balance sheet total (liabilities) | 30 705.25 | 26 386.85 | 29 092.87 | 30 533.30 | 27 972.89 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated